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Objective. To compare intravenous (IV) sedation and general anaesthesia (GA) for third molar 
surgery in terms of patient anxiety, satisfaction, choice and, oral-health-related quality-of-life 
(OHRQoL). 
Study Design. A quasi-experimental design was used, with a clinical convenience sample of 
patients requiring the removal of two mandibular third molar teeth. Each participant was 
consulted by an oral and maxillofacial surgeon or one of their surgical trainees, and they were 
given a free choice between IV sedation and GA for their operation. Participants completed a 
questionnaire before surgery and again 10-14 days afterwards. Data collected before surgery 
included baseline sociodemographic characteristics, OHRQoL, anxiety, aspects of personality 
(positive and negative emotionality) and history of pain. Data collected after surgery included 
the severity of pain, time taken for recovery, OHRQoL, anxiety, and satisfaction with the 
surgery.  
Results. Of the 142 patients, 73 (51.4%) chose to have the operation under IV sedation and 69 
(49.4%) underwent GA. Patients opting for GA scored more highly at baseline on negative 
affectivity and dental anxiety. After surgery, they reported taking more days off before 
returning to normal activities, as well as a higher incidence of sore throat and nausea.  
Conclusion. Patients with negative affectivity and higher anxiety opt for their operation to be 
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Chapter 1: Introduction and Literature review 
 
1.1 Introduction 
The surgical extraction of third molar teeth (wisdom teeth) is one of the most common surgical 
procedures carried out in dentistry (Dodson and Susarla, 2010). The indications for the 
extraction of these impacted teeth include: repeated bouts of pericoronitis; damage to the 
adjacent teeth; associated pathology; and non-restorable carious lesions and/or pulpal 
pathology (Kandasamy and Rinchuse, 2009). Third molar surgery may be undertaken under 
local anaesthesia alone, but more complex impactions may require general anaesthesia (GA). 
Other considerations—such as age, anxiety, general health, pathology associated with the third 
molar, technical difficulty and cost—will also determine the type of anaesthesia. The popular 
perception of third molar surgery being more invasive and traumatic than other forms of oral 
surgery means that it is common for patients to request a GA for their operation. GA is not 
without its own risks and complications, and other options should be offered and considered 
(Brann et al., 1999). For example, intravenous (IV) sedation may be used with local anaesthesia 
(LA) as an alternative. This method has been shown to be safe and reliable for the surgical 
removal of third molars (Garip et al., 2007). To date, comparisons of these anaesthesia methods 
are scarce, and so, surgeons’ recommendations must rely on factors such as the available 
facilities, cost, and their own preferences. 
 
1.2 Literature review 
1.2.1 Third molar surgery outcomes 
In this section, an overview of the surgical outcomes from third molar surgery will be 
discussed. After a brief introduction, common complications such as pain, swelling, trismus 







Third molar teeth are commonly the last teeth to erupt into the oral cavity, and their impactions 
are extremely common. A Swedish paper reported more than 72% of people aged between 20 
and 30 years have at least one lower impacted third molar (Hugoson and Kugelberg, 1988). 
However, a recent meta-analysis of the worldwide prevalence of third molar impaction was 
found to be 24.4% (Carter and Worthington, 2015). The sequelae of impacted third molar teeth 
can result in pain, swelling, repeated bouts of pericoronitis, cyst formation, damage to the 
adjacent teeth and pulpal pathology (Kandasamy and Rinchuse, 2009). Due to the rise in 
surgical complications as we age, the removal of third molars are often carried out in the 
patient's 20s or 30s (Renton et al., 2001; Gbotolorun et al., 2007). As a result, their removal—
whether prophylactic or curative—is one of the top ten in-patient and day-case procedures, and 
therefore makes up a large proportion of the oral and maxillofacial surgery hospital waiting list 
(Shepherd and Brickley, 1994; Worrall et al., 1998).  
This operation is not without complications, with the most common being pain, swelling, 
trismus and alveolar osteitis (dry socket) (Nageshwar, 2002). The sections to follow will review 




Pain is defined as an unpleasant sensory and/or emotional experience that can be associated 
with the presence or absence of tissue damage (Bonica, 1979). Pain after surgery is a normal 
physiologic response. However, there are certain factors that can contribute to an increased 
pain experience.  
Patient age and gender have been associated with pain. Patients in the older age range, >30 
years old, and females have a higher risk of experiencing more pain after surgery 
(Benediktsdottir et al., 2004).  Patients with a less than desirable oral hygiene regime also have 
more post-operative pain (Larrazábal et al., 2010). 
Different mucoperiosteal flap designs have been studied in association with post-operative pain 
(Jakse et al., 2002; Kirk et al., 2007; Goldsmith et al., 2012; Dolanmaz et al., 2013). These 
studies all concluded that there is little difference in pain experience from different flap designs. 
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Kim et al carried out a prospective study where extraction of mandibular third molars were 
carried out without raising a full thickness mucoperiosteal flap (Kim and Choi, 2011). They 
found this technique to significantly reduce post-operative pain. However, the criteria for its 
use were heavily restricted and unlikely to be applicable in more severe impaction cases. 
Medication use has a direct impact on patients’ pain experience post-surgery. Antibiotics have 
been well researched in third molar surgery, and various studies have compared their use pre-
operatively and post-operatively (Arteagoitia et al., 2005; Lacasa et al., 2007; Monaco et al., 
2009; López-Cedrún et al., 2011). A review of randomised control trials by Oomens and 
Forouzanfar concluded that there is limited evidence to support the use of routine antibiotics 
(Oomens and Forouzanfar, 2012). A systematic review published by Marcussen et al concluded 
that a single oral dose of 2g of amoxicillin before third molar surgery significantly decreases 
the incidence of infection and pain (Marcussen et al., 2015). Additionally, Susarla et al 
commented that level 1 evidence suggests that patients undergoing multiple third molar 
extractions will benefit from a single dose of systemic antibiotic administered pre-operatively 
(Susarla et al., 2011).  
The analgesic medication regime is an important aspect of pain control during third molar 
surgery. Ibuprofen is an effective non-steroidal anti-inflammatory drug (NSAID) for pain 
management (Seymour et al., 1998), while other NSAID,—such as diclofenac (Collins et al., 
1998; Shah et al., 2012), other COX-2 inhibitors (Haglund and Bu, 2006; Levrini et al., 2008; 
Tiigimae-Saar et al., 2010; Jacob Liporaci Junior, 2012), tramadol and meloxicam (Isiordia-
Espinoza et al., 2012)—have all been shown to be effective in pain management. The addition 
of opiates (such as codeine) to a NSAID is also common practice; however, a recent double-
blinded randomised control trial showed no difference (Best et al., 2017). Perhaps more 
importantly, the timing of medication—such as the administration of pre-emptive analgesia—
is critical in reducing post-operative pain (Yamaguchi and Sano, 2013). At the time of writing, 
there were no studies that show one analgesic to be superior to another; thus, their choice is 
largely based upon the treating clinician and patient preferences. 
The administration of corticosteroids (such as intravenous dexamethasone) pre-operatively can 
reduce post-operative pain (Baxendale et al., 1993; Buyukkurt et al., 2006; Mehra et al., 2013). 
The use of orally administered corticosteroids such as betamethasone does not seem to provide 
the same reduction in pain relief, but 30mg of oral prednisolone given to patients immediately 
after surgery can be of benefit (Tiigimae-Saar et al., 2010; Marques et al., 2014). Even though 
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there seems to be conflicting evidence, the use of short-term corticosteroids is beneficial in 
managing post-operative discomfort, with minimal side-effects (Ngeow and Lim, 2016). 
A longer operation time has been shown to increase post-operative pain (Benediktsdottir et al., 
2004). This may be directly related to the surgeon’s experience, since less experienced 
surgeons have a higher incidence of complications (Sisk et al., 1966; Capuzzi et al., 1994).  
The use of hilotherapy, an alternative to cryotherapy, has been trialled in recent times to 
manage post-operative pain. It utilises a contoured facemask and delivers cooled water (15 °C) 
that runs adjacent to the skin, avoiding iatrogenic cold injury (from ice packs) and poor 
compliance (Bates and Knepil, 2016). This therapy is encouraging, with recent studies in 
maxillofacial trauma and orthognathic surgery showing dramatic improvement in patient-
reported pain (Modabber et al., 2013; Bates and Knepil, 2016; Glass et al., 2016; Veitz-Keenan, 
2016). 
In summary, pain after third molar surgery is to be expected, and a multitude of different 
strategies have been suggested and used to manage this common post-operative complication. 
The subjective nature of pain means that it can be difficult to ascertain the ideal strategy for 
any given situation, and so it must be evaluated individually.  
 
1.2.1.3 Swelling 
Swelling is defined as a “transient abnormal enlargement of a body part or area not due to cell 
proliferation” (Dorland’s Medical Dictionary). Swelling after third molar surgery is a common 
complication, and its severity varies among patients. Different strategies have been suggested 
for its management, and they are reviewed in this section.  
The use of corticosteroids in surgery has been well documented and widely used (Baxendale 
et al., 1993; Buyukkurt et al., 2006; Graziani et al., 2006; Tiigimae-Saar et al., 2010; Alcântara 
et al., 2014). A recent systematic review by Herrera-Briones and co-workers on the use of 
corticosteroids in third molar surgery concluded that their administration significantly 
improves post-operative swelling, especially if it is used pre-operatively and administered 
parenterally (Herrera-Briones et al., 2013).  
The use of hilotherapy—as previously mentioned—not only aids in pain, it dramatically 
reduces post-operative swelling, especially in the first 3 days after surgery (Modabber et al., 
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2013; Bates and Knepil, 2016; Glass et al., 2016; Veitz-Keenan, 2016). Although those results 
are encouraging, Bates and Knepil did mention that the available studies in their meta-analysis 
were limited with low numbers, and a large variability in study design and analysis. Further 
well-designed trials are required to confirm its efficacy.  
Numerous studies have investigated flap designs and their influence on post-operative swelling 
(Jakse et al., 2002; Kirk et al., 2007; Goldsmith et al., 2012; Dolanmaz et al., 2013). These 
studies all consistently showed that different flap designs do not significantly influence post-
operative swelling. However, the closure of surgical flaps does influence post-operative 
swelling, with primary closure resulting in significantly greater post-operative swelling 
(Pasqualini et al., 2005; Danda et al., 2010).  
Other medications that have been trialled to investigate their effects on swelling are antibiotics 
and analgesics  (Bjørnsson et al., 2003; Lacasa et al., 2007; Kaczmarzyk et al., 2007; Monaco 
et al., 2009). These studies did not conclude whether the use of these medications was effective 
in reducing the severity of post-operative swelling after surgery, however.  
Patient characteristics (such as age and gender) has been related to more post-operative 
swelling after third molar surgery (Yuasa and Sugiura, 2004; Kim et al., 2006). These studies 
concluded that males and patients over the age of 30 developed more post-operative swelling.  
In summary, different therapies have been trialled for the management of post-operative 
swelling. The use of corticosteroids has been well-documented and shown to be effective for 
reducing its severity. Newer therapies such as hilotherapy are encouraging, while there is no 
evidence that either surgical flap design or the use of antibiotics has any benefit.  
 
1.2.1.4 Trismus 
Trismus is defined as a "motor disturbance of the trigeminal nerve, especially spasm of the 
masticatory muscles, with difficulty in opening the mouth (lockjaw), a characteristic early 
symptom of tetanus” (Dorland's Medical Dictionary).  
There are several factors that can cause a patient to develop trismus. Infection, trauma, 
temporomandibular joint disorders, radiotherapy, chemotherapy, and congenital defects can all 
cause the normal range of mouth opening of 40-60mm to decrease (Dhanrajani and Jonaidel, 
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2002). For the purpose of this literature review, studies will be limited to trismus arising from 
third molar surgery.  
A 2-year prospective study carried out by Grossi et al, identified various pre-operative factors 
that were associated with severe trismus after third molar surgery. These were older patients 
(older than 22 years of age), females, ramus relationship, tobacco use, intra-operative bone 
removal and deeply impacted molars (Grossi et al., 2007).  
The relation of different operative techniques to the severity of post-operative trismus has been 
studied. The use of different surgical flap designs was investigated because it is relatively easy 
to learn and modify for research, and it had been hypothesised that modification of the flap 
design might avoid damaging the surrounding structures (such as the buccinator muscle), thus 
reducing the degree of trismus (Jakse et al., 2002; Nageshwar, 2002; Kirk et al., 2007; Kim and 
Choi, 2011; Goldsmith et al., 2012; Dolanmaz et al., 2013). These studies consistently 
concluded that flap design did not have any influence on post-operative trismus.  
The lingual split surgical technique has been shown to result in less trismus (Yates et al., 1979). 
However, this technique is now less frequently indicated due to the high risk of lingual nerve 
damage (Mason, 1988; Valmaseda-castellón et al., 2000; Pichler and Beirne, 2001; Renton and 
McGurk, 2001).  
The administration of intravenous corticosteroids (such as dexamethasone) can reduce trismus 
after third molar extractions (Graziani et al., 2006; Beirne, 2013; Alcântara et al., 2014). 
However, corticosteroids—such as methylprednisolone (Ustun et al., 2003; Alcântara et al., 
2014) or betamethasone (Marques et al., 2014)—do not result in any improvement in the degree 
of trismus.  The use of corticosteroids—as mentioned in the previous section—has a beneficial 
effect on the severity of post-operatively swelling, which can also have a positive effect on the 
degree of trismus that patients experience.  
Cryotherapy does not appear to benefit the degree of trismus post-operatively, but the use of 
hilotherapy may be helpful (Laureano Filho et al., 2005; Rana et al., 2011). In the latter study, 
they compared the use of the Hilotherm cooling device with conventional ice packs, and 
concluded that the use of the device improved trismus post-operatively and reduced the 




In summary, trismus is a common complication of third molar surgery. The existing literature 
shows that pre-operative factors such as severity of the impaction are significant predictors for 
trismus, while operative technique and the use of corticosteroids do not seem to have an effect. 
Newer technologies such as the Hilotherm cooling device appear to be of benefit, especially in 
maxillofacial surgery, but this is a costly capital expense for routine third molar surgery.  
 
1.2.1.5 Alveolar osteitis 
Alveolar osteitis (AO), commonly known as dry socket, is defined as post-operative pain inside 
and around the extraction site, which increases in severity at any time between the first and 
third day after the extraction; it may be accompanied by a partially or totally disintegrated 
blood clot within the alveolar socket, with or without halitosis, and with pain occasionally 
radiating up to the ear and temporal region (Kolokythas et al., 2010). It was first described in 
the literature by Crawford in 1896 as the condition known as dry socket. Since then, many 
other terms have been used, such as localised osteitis, post-operative alveolitis, alveolalgia, 
alveolitis sicca dolorosa, septic socket, necrotic socket, localised osteomyelitis and fibrinolytic 
alveolitis (Birn, 1973; Blum, 2002).  
The incidence of AO in the literature is variable. AO can occur after routine dental extractions 
and is reported to be in the range of 0.9% to 3.2% of cases (Fridrich and Olson, 1990). The 
incidence after third molar surgery is much higher, with reports ranging up to 45% (Fridrich 
and Olson, 1990; Larsen, 1991; Larsen, 1992; Blum, 2002; Sweet and Butler, 2011). This 
variability is partly due to the inconsistencies in the literature’s AO definition and method of 
assessment (Blum, 2002). Irrespective of its incidence, AO is a painful post-operative 
complication and the patient may require up to 4 additional visits to manage the condition 
(Larsen, 1991). 
The aetiology of AO is multi-factorial. A case series of over 10,000 extractions found 
predisposing factors to be female gender, being aged 30-34 years, a smoker, or having 
traumatic or multiple extractions (MacGregor, 1968). Other considerations—such as 
inexperienced surgeon, oral contraceptive use, flap design, physical dislodgement of blood clot, 
pre-existing pericoronitis, fragments remaining in the wound, and excessive irrigation—have 
all been suggested as contributing factors (Nitzan, 1983; Larsen, 1992; Blum, 2002; Kirk et al., 
2007; Kolokythas et al., 2010; Azhar Sheikh et al., 2010; Eshghpour and Nejat, 2013).  
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The seemingly unavoidable nature of the occurrence of AO—even in young, healthy, non-
smoking patients—means that many strategies and methods have been proposed to treat it or 
reduce its occurrence. Common preventive measures are the use of antibiotics and 
chlorhexidine rinses, while less frequent strategies include anti-fibrinolytic agents, steroid anti-
inflammatory agents and obtundent dressings (Blum, 2002; Noroozi and Philbert, 2009).  
Prophylactic antibiotics have been suggested to reduce the incidence of AO (Noroozi and 
Philbert, 2009). Locally delivered tetracycline or clindamycin using impregnated gelatin 
sponges or gelfoam and systemic penicillins, metronidazole or erythromycin have all been 
shown to reduce the incidence of dry socket (Goldman et al., 1973; Rood and Murgatroyd, 
1979).  Conversely, other studies have found that systemic pre-operative antibiotics made no 
difference to AO incidence (Bergdahl and Hedstrom, 2004). Even though the use of antibiotics 
remains a controversial issue, a meta-analysis by Ren and Malmstrom concluded that systemic 
antibiotics given prior to surgery were effective in reducing AO and wound infection (Ren and 
Malmstrom, 2007). This conclusion was further verified by another systematic review in 2016 
(Ramos et al., 2016).  
The use of topical antimicrobial agents such as chlorhexidine mouth rinses in prevention of 
AO is well documented. The use of chlorhexidine concentration, of 0.12% and 0.2% pre-
operatively and post-operatively has been shown to reduce AO incidence (Ragno and Szkutnik, 
1991; Hermesch et al., 1998; Noroozi and Philbert, 2009; Sridhar et al., 2011). 
In summary, there are many theories for the aetiology of AO, but smoking, extraction difficulty 
and female gender are widely accepted as predisposing factors. It does appear that AO 
incidence is related to bacterial contamination, since the use of systemic antibiotics and topical 
antimicrobial agents are effective in reducing its occurrence. However, the definition of AO is 




1.2.2 Anaesthesia for third molar surgery 
In this section, an overview of the use of intravenous (IV) sedation and general anaesthesia 
(GA) for third molar surgery will be provided. IV sedation and GA will be defined, followed 
by consideration of the advantages, disadvantages, indications and contraindications of each 
method.  
 
1.2.2.1 Introduction  
Third molar surgery can be carried out under local anaesthesia alone, although more complex 
cases require a GA. However, with the prevalence of dental anxiety as high as 30% in the 
general population (Armfield et al., 2006), it is not surprising that many patients seek this 
option, even if it may not be clinically indicated.  
 
1.2.2.2 Definition of general anaesthesia 
General anaesthesia (GA) is the induction of a state of unconsciousness, with the absence of 
pain sensation over the entire body. It will block the memory of the procedure (amnesia), inhibit 
normal body reflexes, and relax the muscles. The airway is secured by an endotracheal tube, 
and the procedure is carried out by a specialist anaesthesiologist. GA is usually carried out in 
a hospital setting with anaesthetic and nursing teams.  
 
1.2.2.3 Indications and contraindications of GA 
There has been a steady increase in the demand for GA in the United Kingdom (UK) to 
facilitate dental treatment and dental surgery (Hutchinson, 2014). Even though many are due 
to anxiety and behavioural management problems, other indications include: long and 
extensive surgical procedures; small children who may not tolerate treatment under local 
anaesthesia alone; a rare allergy to local anaesthesia; mental disabilities that make cooperation 
difficult; likely ineffective success of local anaesthetic due to acute infection and inflammation; 
and patient-related difficulties such as extreme gag reflexes or limited opening. There are no 
absolute contraindications for a GA. However, older people (over age 75) and those who are 
very old (over the age of 85) pose a greater GA risk (Messieha, 2009). The American Society 
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of Anaesthesiology (ASA) physical status classification system was developed to aid in 
assessing a patient’s anaesthetic risk. Patients’ with an ASA of IV or V are at a higher risk of 
intra-operative morbidity and mortality during GA.  
The decision to carry out third molar surgery under GA is not always related to technical 
difficulties, systemic health status or cooperation difficulties. Sammut et al (2013) compared 
the choice of anaesthesia for mandibular third molar surgery in two different hospitals 
(Edinburgh Dental Institute and St. John’s Hospital in Livingston, UK) and found that one 
centre had a much higher percentage of patients being listed for GA irrespective of difficulty 
(Sammut et al., 2013). The authors concluded that it may be related to the resources available 
in that hospital. Easier access—albeit more expensive services—enables the hospital to provide 
the service, and hence more patients receive a GA, even if it might not be clinically necessary.  
 
1.2.2.4 Advantages and disadvantages of GA 
GA has the advantage of a protected airway by an endotracheal tube as well as a fully 
anaesthetised and paralysed patient. In complex situations, such as the indications mentioned 
in the previous section, a GA will allow the treatment to be carried out successfully, without 
any psychological trauma to the patient.  
Nkanash et al reported the mortality rate from GA and deep sedation between 1973 and 1995 
in Ontario, Cananda. to be 1.4 deaths per 1,000,000 anaesthetics provided (Nkansah et al., 
1997). Included in that study were anaesthetics provided by a dentist, oral and maxillofacial 
surgeon, or dental anaesthetist within a dental office. Even though the safety of anaesthesia has 
improved over time, due to more advanced, thorough and mandatory monitoring, the provision 
of a GA in a dental office is deemed to be unsafe without involvement of an anaesthetist 
(Eramo, 1999).  
Even though a fully paralysed and unconscious patient might seem easier to treat, there are 
several potential complications (both intra-operatively and post-operatively) to note. Security 
of the airway during GA is vital, and communication with the anaesthetist needs to be clear. 
An airway during a GA may be maintained by a laryngeal mask airway (LMA), or an 
endotracheal tube, inserted orally or nasally. An oral airway (such as an LMA or oral 
endotracheal tube) can be cumbersome and restrict full access to the oral cavity, especially 
when a throat pack is also in situ. Certain procedures are also contraindicated for an oral airway, 
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especially operations that require the occlusion to be checked intra-operatively, such as with 
the open reduction and internal fixation of a mandibular fracture. Accordingly, the surgeon 
must be able to liaise with the anaesthetic team on the correct choice for the procedure and be 
able to work with an alternative if the preferred choice is unavailable.  
Chye et al carried out a prospective study of 1,180 cases following oral surgery and concluded 
that a GA had higher complication rates such as nausea and vomiting than local anaesthetic 
and sedation (Chye et al., 1993). A study of 266 patients in the UK also reported more 
complications with a GA, and concluded that there were significantly greater post-operative 
demands, and with greater job disruptions (Edwards et al., 1998). 
A higher reported incidence of lingual and inferior alveolar nerve damage has also been 
documented, irrespective of surgical difficulty during third molar surgery under a GA (Brann 
et al., 1999). Brann and co-workers commented that the surgical force and the extent of soft 
tissue retraction were greater under GA, which explains the five-fold greater incidence of nerve 
injury.   
The recovery phase during a GA is especially critical. A study on deaths related to dentistry 
found that more than half occurred during this period, especially in children (Tomlin, 1975; 
Brett and Jack, 1993; Coplans and Curson, 1993). In adults, the risk of laryngospasm after 
removal of the endotracheal tube is a known complication, and so essential monitoring is 
paramount during the recovery phase by the anaesthetist and recovery team (Hutchinson, 
2014). 
The financial cost of hospitalisation is a major disadvantage, especially in the private sector. A 
report from Western Australia showed that a large majority of patients who elected a GA for 
their operation by an oral and maxillofacial surgeon were insured, young and healthy 
individuals (George et al., 2011; Anjrini et al., 2015). There were no data on the complexity of 







1.2.2.5 Definition of intravenous (IV) sedation 
Conscious sedation is a state in which the patient is kept from losing complete consciousness 
and retains the ability to independently maintain an open airway. Patients undergoing conscious 
sedation will have the ability to respond to verbal and physical commands. Anxiety can be 
reduced and a variable degree of amnesia may also ensue. It is usually undertaken using a 
parenteral or intravenous (IV) route, but it can also be achieved through an oral or nasal route. 
Sedation is a continuum that ranges from light sedation (or anxiolysis) through to general 
anaesthesia (American Society of Anesthesiologists Task Force on Sedation and Analgesia by 
Non-Anesthesiologists, 2002). A summary of this gradual continuum is presented in Table 1.1. 
Midazolam is a benzodiazepine that binds to gamma-amino-butyric acid (GABA) receptors 
and increases the influx of chloride ions into the neuron, inhibiting depolarisation. It produces 
clinically beneficial effects such as anxiolysis, anterograde amnesia and sedation. However, 
these receptors are also present in the amygdala and hippocampus, and hence play a role in 
emotional regulation, resulting in a risk to the degree of disinhibition (Honan, 1981; Hall and 
Zisook, 1981). Midazolam is widely used in the dentistry, both orally and parentally, and it is 


















































































































































































































































































































































1.2.2.6 Indications and contraindications for IV sedation 
Operations such as third molar surgery can be carried out under local anaesthesia (LA) only. 
However, dental anxiety and patients’ perceptions of oral surgery means that many patients 
and clinicians seek ways to increase acceptability and comfort. In third molar surgery, IV 
sedation can be used in conjunction with LA, and it is indicated for patients graded ASA I or 
II, or for cases that do not require extensive surgery (Garip et al., 2007). A further indication 
for IV sedation includes patients with a significant gagging reflex, as shown by Yoshida et al 
(Yoshida et al., 2007). That study had a small sample size of only 10 participants undergoing 
prosthodontic treatment, but the authors concluded that IV sedation allowed patients with a 
pronounced gag reflex to be treated in comfort. However, they utilised a deeper form of IV 
sedation with Propofol.  
Relative Contraindications include: pregnancy (due to potential birth defects from midazolam); 
hepatic disease (due to alteration of drug metabolism); thyroid dysfunction (due to gland 
hypersensitivity to central nervous system depressants, and the difficulty of sedation in the 
cases of hypothyroidism and hyperthyroidism respectively); and morbid obesity (due to the 
difficulty of locating superficial veins, along with the concurrent cardiovascular, pulmonary 
and hepatic complications). Paediatric and geriatric patients are also relatively contraindicated 
for IV sedation in the dental setting; these groups of patients are more susceptible to 
disinhibitory reactions as well as the management potential medical complications of treating 
older people (McKenzie and Rosenberg, 2010).  
 
1.2.2.7 Advantages and disadvantages of IV sedation 
The use of midazolam in IV sedation has the advantage of a rapid onset and a good level of 
amnesia, both of which are beneficial during dental surgery (Skelly and Craig, 2005). It has 
also been shown to be effective in controlling anxiety during third molar surgery (Van Der Bijl 
et al., 1987; Bell and Kelly, 2000; Jerjes et al., 2005). A prospective study was carried out to 
demonstrate the effectiveness of pre-medication using midazolam before ambulatory surgery 
(Bauer et al., 2004). It found that the group that received midazolam reported less post-
operative nausea and vomiting (PONV), a lower anxiety level after administration, and a 
greater post-operative satisfaction.  The safety of midazolam is also due to the availability of 
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flumazenil, a quick-acting benzodiazepine antagonist. Flumazenil can reverse the effects of 
sedation, hypnosis, respiratory depression and any paradoxical reactions (Cabrera et al., 2010).   
By keeping patients at a state of sedation where verbal command is possible, the level of 
sedation can also be titrated to effect, depending on individual patient needs. This reduces the 
risk of overdose or inadequate sedation, and makes it a safe and satisfactory technique 
(Zacharias et al., 1998; Kucukyavuz and Cambazoglu, 2004). This level of sedation also allows 
for a relatively quick recovery period.  
However, over-sedation is one of the biggest risks in IV sedation. The boundary between 
conscious sedation and GA cannot be identified (Halloran, 2013; Peden and Cook, 2014). As 
the depth of sedation increases, patients will lose their protective pharyngeal and laryngeal 
reflexes, resulting in a loss of the ability to maintain their own airway. When combined with 
the copious amounts of saline irrigation used during third molar surgery, IV sedation presents 
a risk to airway patency.  
Unexpected reactions—termed paradoxical reactions—from the use of midazolam have been 
well-documented, especially in relation to children. These complications include 
hallucinations, disorientation, uncontrollable crying or verbalisation, agitation, restlessness, 
involuntary movement, and aggressive behaviour (Moon, 2013; Shin et al., 2013). Even though 
these reactions are not deemed a risk to the patient’s airway and safety, they render dental 
treatment impossible. The mechanism of this reaction is unknown, and its occurrence is not 
isolated to children (Van Der Bijl and Roelofse, 1991; Cabrera et al., 2010; McKenzie and 
Rosenberg, 2010).  
 
1.2.2.8 Choice of anaesthesia  
A report in 1999 established that a GA for dental purposes should be avoided wherever possible 
if other techniques are possible (Tyrer, 1999). There is evidence in the paediatric literature that 
large proportion of patients referred for GA can be successfully treated under local anaesthesia 
and sedation (Shaw et al., 1996).  
Edwards and co-authors reported that patients are often unnecessarily referred for treatment 
under GA for their operation, and 42% of patients could have been treated under ambulatory 
care (Edwards et al., 1998). There has been a gradual change in the rationale between GA and 
IV sedation, and recently, third molar surgery  is performed as a day-stay, outpatient procedure, 
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rather than an inpatient hospital one (Dunne et al., 2006). The decision to treat under a GA 
might be due to convenience because of the facilities on offer rather, than the difficulty of the 
operation (Sammut et al., 2013). Other studies from larger hospital units that have easier access 
to operating theatre facilities have also reported to carry out more third molar operations under 
GA (Kim et al., 2006). 
The experience of the treating consultant has been proposed to be an influence on the choice 
of anaesthesia. In the Edwards et al study, more experienced consultants were more likely to 
treat patients under local anaesthesia, while Sammut et al found the opposite, where by surgical 
trainees were less likely than their consultants to recommend a GA (Edwards et al., 1998; 
Sammut et al., 2013).  
Ultimately, patients are required to make an informed decision. In the Sammut et al study, they 
found patients from more socially deprived areas were more likely to opt for a GA (Sammut et 
al., 2013). They concluded that patients from areas of greater social deprivation had a potential 
to make “less healthy” decisions, tending to choose a GA for their operation.  
Thus, the choice between IV sedation and GA is not as simple as determining the surgical 
difficulty or assessing the patient’s medical fitness. Factors such as anxiety, cost, availability 
of facilities, surgeon’s preferences and social factors all play a role in influencing this choice.   
 
1.2.2.9 Comparison between IV sedation and GA 
High level evidence, such as a systematic review, for the comparison between IV sedation and 
GA in third molar surgery in the literature is absent. However, smaller studies have shown the 
use of IV sedation to be safer and cheaper than a GA, resulting in fewer post-operative 
complications in procedures other than third molar surgery (Van Sickels and Tiner, 1992; Bayat 
and Arscott, 2003).  
Comparison of surgical recovery and success has been carried out with a genioplasty procedure 
(Van Sickels and Tiner, 1992). The authors commented that deep sedation—with the addition 
of methohexital during the bone cuts—was cheaper, showed quicker recovery, and resulted in 
the same surgical outcomes as a GA. Even though their conclusion was that IV sedation is 
safer, only eight patients underwent the procedures, with two patients reported as being over-
sedated during the operation, needing to be awakened before completion of surgery. Their 
discussion mentioned that the assistant was also required to maintain a fluid-free airway as well 
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as keeping the surgical area visible; this leads to greater stress and a less-than-ideal surgical 
scenario.  
IV sedation and GA comparisons with temporomandibular joint arthrocentesis were also 
undertaken (Mehra and Arya, 2015). This study reported that the procedure can be successfully 
carried out under IV sedation in an office set-up. However, a much superior clinical outcome 
was offered when it was performed under GA with a secured airway. In that study, deep 
sedation was also used with a combination of midazolam, fentanyl, a propofol infusion, and at 
times, ketamine. A heavily sedated patient also required a bite block to maintain an airway. 
And this restricted the jaw manipulation required for the procedure. A patient under GA will 
have greater muscle relaxation, allowing the necessary manipulation of the mandible for 
carrying out successful treatment. They concluded that a GA would be safer, more predictable 
and less invasive. 
By contrast, a paper published in 2014 comparing IV sedation and GA for patients needing 
maxillofacial surgery (for mandibular fracture or TMJ ankylosis) found that the IV sedation 
group experienced a longer pain-free period and required lower doses of rescue analgesia; there 
were no reports of sore throat and fewer episodes of PONV (Rastogi et al., 2014). These 
resulted in earlier discharge than the GA group. Surgeon satisfaction was also acceptable. 
However, deep sedation was used in this study using propofol, in addition to a naso-phayngeal 
airway.  
Comparison of these two anaesthesia methods has been carried out with children requiring 
dental work. A UK study evaluated the efficacy of IV sedation instead of a GA when 
performing surgical exposures and/or dental extractions in children (Dorman et al., 2007). 
Although it used a small sample, nearly all the children underwent treatment, which would 
have otherwise been done as a day case GA. A similar study of nearly 1,000 children 
undergoing dental work was carried under IV sedation, using a combination of midazolam, 
alfentanil and ketamine (Mikhael et al., 2007). The authors commented that conscious sedation 
can be carried out for dental work on such children, ranging from 3 years of age to 10 years, as 
long as the strict definition of conscious sedation is adhered to. When the correct titration is 
achieved, it is safer than a GA.  
The medical literature has made similar comparisons between IV sedation and GA. In a study 
comparing oxygen saturation between GA and IV sedation with paediatric patients undergoing 
esophagogastroduodenoscopy, there was a much lower oxygen saturation level in the sedation 
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group (Lamireau et al., 1998). They deemed a GA to be a much safer technique for carrying 
out their procedure. This study also rated operator satisfaction with the procedure; almost all 
of the procedures done under the GA group received a "very good condition" score, while the 
IV sedation group varied considerably, with 50% reporting an “incomplete procedure” and 
only 20% reporting “very good conditions”. 
A study on microwave endometrial ablation was published in 2001 comparing treatment 
success between GA and LA with IV sedation (Bain et al., 2001). Participants were divided 
into two groups; one group was randomly allocated to their anaesthesia method, while the other 
had a free choice. The participants who chose to have their operation under LA with IV sedation 
had a quicker recovery, requiring a lesser amount of post-operative analgesia. In addition, 
participants who had a free choice of their anaesthesia method, was more accepting of the 
procedure than the randomly allocated group.  
In a large study involving 421 patients undergoing a range of plastic surgery procedures, Bayat 
and Arscott carried out all procedures under LA and IV sedation, as an alternative to GA (Bayat 
and Arscott, 2003). Not only did they successfully carry out all the procedures safely, they 
commented that IV sedation resulted in shorter hospital stay, costed less, had fewer post-
operative complications, and enabled a quicker return to work. They concluded that IV sedation 
was a useful and safe anaesthetic technique for relatively short procedures. Successful 
outcomes required careful patient selection, the presence of trained personnel, emergency back-
up equipment and a safe titration of the midazolam dosage.  
Intra-arterial mechanical thrombectomy (IAMT) is a procedure that is carried out for the 
treatment of an acute ischaemic stroke (AIS). There is controversy in the medical literature 
over whether this should be performed under IV sedation or GA (John et al., 2013). They 
concluded that due to the urgency of this procedure, IV sedation should be considered. They 
also commented that the presence of a pain response during IV sedation can actually be 
beneficial to the procedure and the surgeon can adjust various factors such as the dilation of 
the balloon intra-operatively. McDonald and co-workers compared IV sedation and GA for 
2512 patients undergoing thrombectomy for AIS (McDonald et al., 2014). The IV sedation 
cohort had a shorter hospital stay, fewer post-operative complications, and lower costs. 
However, the authors did comment that patients who had more severe strokes would have 
received a GA.   
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Thus, the comparisons between IV sedation—especially light, to moderate conscious 
sedation—and GA for third molar surgery are limited in the current literature. Sedation 
techniques vary greatly in the existing research, with many using a combination of different 
medications and sedatives to achieve the desirable effect. These techniques require advanced 
training and additional human resources during the procedure, and are unsuitable for an in-
office, dental sedation.  
 
1.2.3 Oral-health-related quality-of-life (OHRQoL) 
The section that follows gives a brief history of the use of quality-of-life information in the 
literature and its importance in dental research. The use of such measures in third molar surgery 
is then summarised.  
 
1.2.3.1 Introduction 
Assessment of the physical, social and psychological consequences of health states had been 
carried out for several decades now in medicine, but only recently has it been employed in the 
dental arena. While a great body of evidence exists about the possible signs and symptoms 
following third molar surgery in terms of pain, swelling, trismus, and paraesthesia, surprisingly 
little is known about the consequences of these on a patient’s life, and how it affects day-to-
day life or life quality (McGrath et al., 2003) 
The primary aim of clinical care is to treat our patients to the best of our ability and ultimately 
improve patient outcomes. However, it has been recognised that past research does not evaluate 
these outcomes by considering both traditional clinical variables and psychosocial factors 
(Wilson and Cleary, 1995). The realisation that there is more to patient outcomes than 
measurable clinical data was reported in the early 1980s (Schipper, 1983). Schipper also 
commented that clinicians can provide treatments that are theoretically successful, but in 
reality, a poorer outcome from the patient’s perspective. Therefore, there was a growing 
interest in measuring people's quality-of-life and expanding our evaluation of treatment 
outcomes beyond objective clinical data. In addition, quality-of-life measurements can also be 
used to measure a population’s well-being or treatment needs (Hennessy et al., 1994).  
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The Oral Health Impact Profile (OHIP) was developed and used to measure people’s oral-
health-related quality-of-life (OHRQoL). It utilises 49 questions to evaluate each individual’s 
perception of the impact of their oral condition on their own well-being (Slade, 1997). The 
OHIP instrument has been used successfully in randomised control trials to evaluate treatment 
outcomes after implant therapy (Awad et al., 2000; Allen et al., 2001). However, the 49-item 
questionnaire was too long, and so the OHIP-14 was developed (Slade, 1997; Locker and Allen, 
2002). Locker and Allen stated that the shorter form may be preferable when the aim is to 
detect a change in a clinical intervention type study (Locker and Allen, 2002). 
 
1.2.3.2 OHRQoL and third molar surgery 
As mentioned in the previous section, the increasing interest in oral-health-related quality-of-
life (OHRQoL) in our patients is important in our understanding of treatment success. The 
OHIP-14 has been widely used in recent times not just for the evaluation of treatment outcomes, 
but in wider population research. The consideration of OHRQoL after wisdom teeth surgery 
was suggested in the late 1990s and it was encouraged that clinicians include the impact of 
OHRQoL in their informed consent (Savin and Ogden, 1997).  
The pre-operative condition of third molars has a direct impact on OHRQoL. Symptomatic 
third molars, especially those with pericoronitis, dramatically influence people’s OHRQoL 
(McNutt et al., 2008; Magraw et al., 2015). Patients undergoing surgery with existing 
symptoms will have up to 3 times greater impact on their OHRQoL (Slade et al., 2004). 
However, in some studies, patients who had experienced symptomatic pericoronitis reported a 
significant improvement to OHRQoL after surgery (Bradshaw et al., 2012).  
The surgical removal of third molars involves a definite deterioration of patients OHRQoL 
after surgery, especially in the first post-operative week (McGrath et al., 2003; Colorado-
Bonnin et al., 2006; Deepti et al., 2009; Sancho-Puchades et al., 2012). McGrath et al 
commented that surgical oedema following third molar surgery was one of the common 
complications that impacted on OHRQoL (McGrath et al., 2003). Delayed clinical healing, or 
the development of complications after surgery, will negatively impact on OHRQoL with an 
greater pain, slower restoration of oral function and a delay in the return to a normal lifestyle 
(Ruvo et al., 2005; van Wijk et al., 2009). A study from Brazil found that this deterioration was 
not related to surgical duration and difficulty (Sato et al., 2009). 
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As Savin and Ogden noted in 1997, surgeons should include the impact of surgery on 
OHRQoL. Even in the presence of satisfactory clinical healing, OHRQoL can still be impacted 
negatively. Therefore, more understanding of both clinical and OHRQoL data after third molar 
surgery can better inform patients about the realistic expectations after surgery, and so provide 
more rounded clinical care (McGrath et al., 2003; White et al., 2003).  
 
1.2.4 Dental anxiety 
The sections that follow summarise the current understanding of dental anxiety and how it 
impacts on third molar surgery. This section also gives an overview of the use of IV sedation 
with dentally fearfully patients.  
 
1.2.4.1 Introduction 
The prevalence of dental anxiety in the general population can be as high as one in three 
individuals (Armfield et al., 2006). The impact of this has a snowball effect in the community, 
with dentists and dental treatment being one of the most common fears among the general 
population (Fiset et al., 1989). Dentally anxious patients are more likely to cancel or fail their 
appointments and be more difficult to treat due to behavioural management problems, thus, 
resulting in overall poorer dental health (Eitner et al., 2006). This fear is further heightened in 
exodontia procedures, especially when rotary instruments are to be used (Earl, 1994). It is 
logical to assume then, that surgical removal of third molar teeth will heighten anxiety in 
vulnerable patients.  
 
1.2.4.2 Dental anxiety and third molar surgery 
Typically, studies have evaluated the difficulty of third molar surgery using clinical variables. 
Traditionally, the degree of impaction, angulation, proximity to the nerve canal, angulation of 
the second molar are evaluated from a panoramic radiograph of the jaw bones, in order to assess 
difficulty (García et al., 2000; Akadiri and Obiechina, 2009). Patient characteristics (such as 
age, ethnicity, and gender) were also evaluated in recent times in assessing difficulty (Renton 
et al., 2001). However, psychosocial factors such as dental anxiety are also an important 
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variable (Aznar-Arasa et al., 2014). Aznar-Arasa and co-workers concluded in their study of 
102 patients that extractions of third molars in highly anxious patients were significantly more 
difficult. A Korean study also found that high anxiety levels pre-operatively directly affected 
the surgical outcome, in terms of pain and satisfaction (Kim et al., 2010).  
Pre-operative anxiety levels can influence various coping behaviours post-operatively. George 
et al concluded that this leads to poorer healing, longer swelling, and greater disability (George 
et al., 1980). They concluded that, if clinicians can accurately communicate more effectively 
the expectations from surgery, patients might be able to manage their pre-operative anxiety 
better. This concept of managing surgical outcomes with accurate pre-operative information 
has been studied and shown to be effective in managing pain after surgery (Vallerand et al., 
1994).  
 
1.2.4.3 Dental anxiety and IV sedation 
IV sedation using midazolam alone is an effective method to control anxiety during the surgical 
removal of third molar teeth (Van Der Bijl et al., 1987; Bell and Kelly, 2000; Jerjes et al., 
2005). These studies all concluded that the administration of midazolam intravenously 
decreased patients’ anxiety levels, and allowed treatment to be a success. There were minimal 
complications and it was well accepted by patients. In the Jerjes et al study, they did not use 
midazolam as a sedative, but as a pre-med prior to GA, and they also found that its use had no 
adverse effect in a healthy patient.  
In addition to the lower risks of IV sedation, conscious sedation can result in lower anxiety 
post-treatment than with a GA (Arch et al., 2001; Kupietzky, 2004). Arch and co-workers 
carried out a study of 88 children, 9-15 years of age, investigating how conscious sedation and 
GA can impact on dental anxiety (Arch et al., 2001). The parents and the child were informed 
about the benefits of sedation; those who went ahead, were able to be successfully treated 
without the need for a GA. Even though this study used nitrous oxide conscious sedation 
(NOCS), it is worthwhile to note that the children in the NOCS group reported post-surgery 
lower dental anxiety than the GA group. Post-operative anxiety in relation to third molar 
surgery has also been explored (Bell and Kelly, 2000), showing that 2 weeks post-operatively, 
the sedated group reported lower anxiety. 
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The use of IV sedation is effective in managing patient’s anxiety levels during surgery. 
However, the available studies differ in their use of midazolam, and very often, combinations 
of different sedatives were used in the research. The measurement of anxiety was also 
inconsistent and this makes comparisons difficult. To date, there are no studies which have 
evaluated patients’ dental anxiety with their choice in anaesthesia, or by surgical outcomes.  
 
1.2.5 Personality 
This section will introduce the concept of personality and its relevance to dental research.  
 
1.2.5.1 Introduction 
Psychosocial factors are important in evaluating surgical difficulty and outcomes. In addition 
to dental anxiety, psychosocial characteristics such as personality traits can influence patient 
choice and outcomes. The study of personality traits is relatively new to dental research and its 
application in dental research is limited. There has been no evaluation of personality traits and 
its influence their third molar surgery.  
 
1.2.5.2 Personality in dental research 
The use of data on psychological traits such as personality is relatively new in oral health 
research. General health had been recognised as a subjective state, and individuals can interpret 
their own symptoms differently. Kressin et al found that psychosocial characteristics such as 
personality influence perceptions of oral-health-related quality-of-life (Kressin et al., 2001).  
Personality has been shown to be an important influence on dental disease, especially dental 
caries and its sequelae (Thomson et al., 2011). In a prospective study, of a birth cohort born in 
Dunedin, (New Zealand), personality was measured using the Multidimensional Personality 
Questionnaire (MPQ) and OHRQoL using the short-form Oral Health Impact Profile (OHIP-
14). The MPQ scale consists of three main superfactor of “constraint”, “negative emotionality” 
and “positive emotionality”. These are further divided into 10 independent subscales that 




Table 1.2: Overview of the Multidimensional Personality Questionnaire (MPQ) scale  
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The constraint factor reflects on individuals’ traditionalism and self-control. Individuals 
scoring lower in this category tend to be fearless and impulsive, while higher scores tend to be 
more conventional and cautious in their thinking. The positive emotionality factor reflects on 
individuals’ happiness, wellbeing, social potency and achievement. High scorers in this 
category are generally “happy people” with the tendency to feel more positivity from their 
experiences, while low scorers are less likely to be happy and report fear from otherwise 
pleasurable experiences. Lastly, the negative emotionality factor reflects on individuals’ 
aggression, alienation and stress reaction. Individuals scoring highly on these traits tend to be 
stressed, feels mistreated and betrayed, and exhibit a degree of catastrophising.  
In the Thomson et al study, they showed that those scoring higher on negative emotionality 
had a greater risk of having caries and psychosocial characteristics also shaped self-reported 
oral health. The authors hypothesised that, because personality can change over time, or 
through brief cognitive interventions, it might be of value to preventive dentistry. This study 
concluded that the use of OHRQoL measures (such as OHIP-14), while a very useful tool, will 
be subjected to a degree of “contamination” by personality, especially from the negative 
emotionality domain. The MPQ that is used in this study contains 177-items, which is rather 
unwieldy to use in clinical research. Accordingly, they suggested that a shorter measure such 
as the Positive and Negative Affect Schedule (PANAS; Watson et al., 1988) would be more 
efficient. The PANAS has recently been validated for use in oral health research (Ibrahim, 
2014).  
A study carried out in 1995 also investigated the effects of psychosocial parameters such as 
personality, coping styles and anxiety on third molar surgery (Gidron et al., 1995). The surgery 
was evaluated by an oral surgeon and carried out under LA and IV sedation. Interestingly, after 
controlling for the difficulty of the surgery, they found that negative affectivity, emotion-
focused coping and parental pampering affected mouth opening, functional disability, and pain. 
An earlier study, attempted to relate personality characteristics to the use of analgesics and 
reported pain (Hansson et al., 1989). It concluded that operations carried out in the afternoon 
required more analgesics, while patients who were in higher levels of distress also demanded 
more pain relief. However, no data on the surgical difficulty of the surgery was reported, and 
the analgesic regimen used in the groups was no consistent.  
In summary, the use of psychosocial concepts—such as personality—is in its infancy in dental 
research. Early findings are encouraging and further research into their influence into health 
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care is warranted. There have been no studies in the existing literature where the use of 




Chapter 2: Rationale for research 
 
2.1 Summary of literature review 
The surgical removal of third molar teeth is one of the most commonly performed surgical 
procedures in dentistry (Dodson and Susarla, 2010). They present in the oral cavity in 
numerous angulations and positions, and at times, are associated with cysts and other 
pathologies (Kandasamy and Rinchuse, 2009). Their removal may be undertaken under local 
anaesthesia (LA) alone, but more complex impactions may require the additional use of 
intravenous (IV) sedation or general anaesthesia (GA).  
IV sedation and GA each carry their own advantages and disadvantages. The choice remains a 
controversial topic among clinicians. Decisions can be made based upon available facilities, 
clinician preferences and experience, patient-related factors such as anxiety, medical health, 
social standings and surgical difficulty(Kim et al., 2006; George et al., 2011; Sammut et al., 
2013). No clear rationale for the choice has been identified.  
To date, the research on third molar surgical outcomes has primarily on objective clinical data 
such as pain, swelling, trismus, and the incidence of alveolar osteitis (Kirk et al., 2007; 
Goldsmith et al., 2012; Best et al., 2017). However, in the last decade, there has been an 
increasing awareness that patients’ oral-health-related quality-of-life (OHRQoL) should be 
taken into consideration, along with how surgery impacts on their day-to-day lives (Schipper, 
1983). Self-reported information (such as OHRQoL) is very useful in informing patients on the 
likelihood of their recovery after the surgical removal of third molar teeth (Savin and Ogden, 
1997). This operation significantly affects OHRQoL, especially for the first post-operative 
week (McGrath et al., 2003; Deepti et al., 2009; Sancho-Puchades et al., 2012). This impact is 
even greater in patients who were symptomatic pre-operatively (Slade et al., 2004).  It has also 
been shown that, even in patients where surgical sites are clinically healing as expected, self-
reported experience may differ (Savin and Ogden, 1997).  
An explanation for this can be attributed to people’s psychosocial characteristics, such as dental 
anxiety and personality characteristics. These psychological characteristics can influence 
patients’ pain experience, clinical healing, duration of facial swelling and ultimately, a 
deterioration in quality-of-life and greater disability (George et al., 1980; Gidron et al., 1995; 
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Kim et al., 2010; Aznar-Arasa et al., 2014). It can also influence their interpretation of their 
experiences and therefore impact on their overall satisfaction (Thomson et al., 2011). 
Accordingly, psychosocial characteristics have a large role to play in the interpretation of their 
experience and surgical outcome.  
 
2.2 Research aims 
This study set out to: 
1) compare two anaesthesia methods—IV sedation and GA—and to note any differences 
in their surgical outcomes; and 
2) investigate the impact of personality on patients’ choice and surgical outcomes. 
 
2.3 Rationale for current study 
There have been a few studies comparing IV sedation and GA for oral and maxillofacial 
surgical procedures. These studies compared these two anaesthesia methods via clinical 
outcomes such as treatment success, pain, nausea, vomiting and time to discharge. 
There is more to determining patient outcomes than clinically measured data, and investigation 
into the influence of psychological traits on patient-reported outcomes is warranted. However, 
patient-reported outcomes are often influenced by personality, especially the negative 
emotionality trait. Healthcare providers need to be aware of the impact of patients’ own 
evaluation of their health, and how this can influence on their recovery from surgery. It is 
therefore important to know the association between patient’s psychological traits and surgical 
outcomes.  
To date, there have been no studies investigating the impact of patients’ psychological traits on 
third molar surgery outcomes. This study will be the first to incorporate a personality measure 





2.4 Aims & objectives 
The aims and objectives of the study were: 
1) to compare the surgical outcomes from third molar surgery between two anaesthesia 
methods (as measured by pain experienced, OHRQoL, number of days taken off and 
the number of days where eating pattern are affected); 
2) to compare the differences in patient experience and satisfaction between IV sedation 
and GA (as measured by self-reported patient expectations and satisfaction); and 
3) to evaluate the effects of patients’ personality on surgical outcomes after third molar 
surgery (as measured by the PANAS and IDAF-4C scales). 
 
2.5 Hypothesis 
The use of IV sedation for the surgical removal of third molars is safe, well-tolerated and will 
provide patients with a satisfying experience. IV sedation will also provide a better surgical 
outcome than GA. 
Patients who are dentally fearful and/or higher in negative emotionality will opt for GA for 
their operation.  
Patients with higher negative emotionality will experience a poorer outcome from surgery, 
reporting more pain, more days off work and have lower satisfaction.   
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Chapter 3: Methods 
 
3.1 Ethics approval and Māori consultation 
Prior to the commencement of the study, ethical approval from the University of Otago Human 
Ethics Committee (Health) was gained on 23rd September 2015 (H15/092). The initial decision 
letter and final approval letter is attached as Appendix A.   
Māori consultation was undertaken and approved on 15th September 2015. The Ngāi Tahu 
Consultation Committee letter is attached as Appendix B. Ethnicity data was collected as part 
of the survey.  
 
3.2 Study Design 
This study was a prospective, quasi-experimental study. A quasi-experiment is an experiment 
that investigates an intervention on the study sample without random assignment. Unlike a 
randomised control trial (RCT), where the treatment groups are randomly assigned the 
treatment or control, a quasi-experiment is where the researcher controls the assignment. In 
this case, the patient or participant themselves had control over their intervention. 
 
3.3 Participants 
3.3.1 Patient sample and sample size determination 
A clinical convenience sample was gathered from patients needing the surgical extraction of 
third molar teeth at the Faculty of Dentistry, University of Otago. These patients were either 
self-referred or referred by a dental practitioner to the School of Dentistry for the management 
of their third molars.  
Using participants’ rating of the treatment experience as the dependent variable, and assuming 
60% of those in the GA group and 80% of those in the IV group will report a “good” or 
“excellent” experience, it was estimated that there be 73 in each group (assuming an α level of 
0.05 and 80% power to detect a difference). Thus, 146 participants will be required. The actual 
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number of participants enrolled were higher than the required number. (as described in section 
4.1.1).  
 
3.3.2 Eligibility criteria for participation 
The inclusion criteria for this study were: aged between 16 and 35 years of age; seen by a 
consultant oral and maxillofacial surgeon or by one of their surgical trainees; American Society 
of Anaesthesiologist (ASA) physical status classification system I or II; legitimately requiring 
the removal of two mandibular third molar teeth (and may require removal of uppers)—as per 
guidelines by the National Institute for Health and Care Excellence (NICE); operation carried 
out under LA with IV sedation or GA; voluntary participation of the study.  
The exclusion criteria for this study were patients: aged under 16 and over 35 years-of-age; 
cardiovascular disease; respiratory illnesses; hepatic impairment or disease; renal impairment 
or disease; bleeding disorders or on medication effecting coagulation; bone disorders; 
metabolic diseases; hypersensitivity to benzodiazepines; pregnant or breastfeeding women; 
body weight >120kg; history of drug addiction or current opioid use; patients unable to give 
informed consent; any significant systemic disease classified as ASA III, IV or V; and patients 
who chose to undertake their surgery under local anaesthesia only.  
Third molars excluded from the study were: associated pathologies such as cysts; teeth 
requiring coronectomy; teeth with increased risk of mandibular fracture; teeth with increased 
risk of oro-antral communication; and surgery requiring more than four third molars removed.  
 
3.3.3 Obtaining patient consent 
Patients who met these criteria were provided an information sheet, “Information Sheet for 
Participants” (Appendix C). They were given time and opportunity to ask any questions prior 
to participation. Patients who agreed to participate in the study had a consultation appointment 
with the surgeon. At this appointment, they were requested to sign the “Consent Form” 
(Appendix D) for enrolment into the study.   
Every participant was allocated a unique ID number for anonymity and data analysis. The name 
of each participant was entered into a database alongside their unique ID number. This number 
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was used in all data-entry forms and personal data were kept securely by the principal 
investigator.  
Individual patient questionnaires were not perused at any stage during their active participation 
period to avoid bias.   
 
3.3.4 Participant responsibility 
Patients who participated in this study were required to: Complete the “Before surgery 
questionnaire” form (Appendix E); attend the procedural appointment for the surgical removal 
of third molars; and attend a follow-up appointment 10-14 days after surgery and complete the 
“After surgery questionnaire” form (Appendix F). Participants who were unable to attend the 
post-operative review appointment, but were still willing to participate in the study, the post-
operative questionnaire was mailed to their postal address along with a paid self-addressed 
envelope to return to the principal investigator. 
 
3.3.5 Participant incentives 
At the completion of the study, participants who completed both questionnaires were entered 
in to a prize draw ($200 shopping voucher). The winner was drawn randomly and was 
contacted to claim the prize.  
 
3.3.6 Location and setting of study 
Patients undergoing their operation under local anaesthesia (LA) with IV sedation had the 
procedure performed in the theatre suite, at the Faculty of Dentistry, University of Otago. This 
group of participants will be referred to as the IV sedation group.  
Patients undergoing their operation under GA had the procedure performed in the theatre suite 
(as above), or the day surgery unit at Dunedin Public Hospital. This group of participants will 




3.4 Questionnaire design and data collection 
3.4.1 Socio-demographic characteristics 
This study utilised the socio-demographic characteristics that were used in previous studies 
based on the New Zealand Population (Thomson et al., 1999). They were: age, gender, ethnic 
group (please circle) (NZ/European, Māori, Pacific Islander, Asian/Chinese, Other), 
Community Services Card (CSC) ownership, and highest level of education attained. 
 
3.4.2 Oral health care variables 
Participants were asked a few questions about their oral health habits and the history with their 
wisdom teeth. They were: smoking status; frequency of brushing; mouthwash usage; history 
of pain or discomfort with their wisdom teeth; degree of pain, if any, with their wisdom teeth 
(mild, moderate, severe); and frequency of pain, if any, with their wisdom teeth (occasionally, 
sometimes, often, always).  
 
3.4.3 Preference between IV sedation and GA 
During their consultation with the primary investigator, they were advised that their operation 
can be done equally successfully between (a) LA with IV sedation or (b) GA. Participants were 
given a free choice between these two peri-operative pain control methods (LA+IV sedation or 
GA) for their operation and their respective costs. They were encouraged to ask any questions 
about the differences and were given time to think about their decision and to discuss this with 
friends and family.  
Once they decided, participants were asked if this choice was pre-meditated or if they changed 







3.4.4 Oral Health Impact variables 
Oral health-related quality-of-life assessment data was collected before and after the surgical 
procedure using the OHIP-14 instrument (Slade, 1997). These questions measure people’s 
perception of how their oral health will impact on their well-being. It consists of 14 items, 
divided into two equal subscales from the original long form of this measure. Participants were 
asked “During the last 2 weeks, have you; had painful aching; been self-conscious, …”. 
Responses were scored and recorded as numerical codes: Very Often=4, Fairly Often=3, 
Sometimes=2, Hardly Ever=1, Never=0.  
Post-operative OHIP scores were gathered at their review appointment 10-14 days after their 
surgery. This is the usual review period after third molar surgery and was chosen to best reflect 
real-world clinical setting.  
 
3.4.5 Scale investigating dental anxiety 
The scale used in this study was the IDAF-4C module (Armfield, 2010). This is an 8-item form 
that assesses emotional, behavioural, physiological and cognitive aspects of the fear and 
anxiety response. This relatively new scale has been shown to be effective in assessing dental 
anxiety and fear in the adult population.  
 
3.4.6 Scale investigating positive affect and negative affect 
The Positive and Negative Affect Schedule (PANAS) was used in this study to evaluate the 
impact of positive affect (PA) and negative affect (NA) on surgical outcomes (Watson et al., 
1988). The PANAS scale comprises of 10 questions in each PA and NA categories, and has 
been shown to influence patients’ self-reported oral health (Thomson et al., 2011). 
  
3.5 Surgical procedure 
IV sedation participants received sedation using intravenous midazolam (HypnovelTM; Roche, 
Basel, Switzerland), titrated to effect in 1-mg increments. Dexamethasone (8mg) and Paracoxib 
(40mg) were also administered intravenously. GA participants were intubated nasally with a 
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throat pack and monitored by a specialist anaesthetist. Both groups received Dexamethasone 
(8mg) and Paracoxib (40mg), administered intravenously before the operation. Local 
anaesthesia was given, and the surgical technique was similar between both groups with a 
standard approach—with exposure of mandibular third molars via a buccal envelope flap with 
a protected lingual flap (if required). All mandibular third molar teeth required bone removal. 
Maxillary third molars were removed simply (fully erupted), or with a simple buccal flap, +/- 
buccal guttering (unerupted or partially erupted).  
All surgical procedures were carried out by oral surgery registrars. A consultant oral and 
maxillofacial surgeon was available at all times for advice or help, but was rarely required.   
 
3.6 Outcomes 
3.6.1 Clinical measures 
Verbal rating scale (VRS) was used to evaluate pain (Mccrirrick and Hunter, 1990). A score of 
1 to 5 was assigned respectively to: “No Pain”, “Mild Pain”, “Moderate Pain”, “Severe 
Pain” and “Excruciating pain & agony”. An ordinal scale was used for its ease of use and 
relates easier to patients.  
The incidence of nausea & vomiting, sore throat and early review by a dentist was recorded in 
the questionnaire, using “Yes” and “No” options. 
Additional data collected was collected on pain behaviour such as: seeing a medical doctor for 
additional pain medication or, taking more, additional, or alternative analgesics by asking “Did 
you take any additional pain relief medication other than the tablets prescribed to you” and 
“Did you need to see your medical GP about your pain or discomfort?”.  
The incidence of dry socket (measured by patient’s attendance and receiving treatment by 
irrigation of the socket with or without socket dressing) was also recorded in the questionnaire, 
using “Yes” and “No” options for the question “Did you require the socket to be irrigated by 





3.6.2 Patient self-reported measures 
VRS was used to assess participants self-reported experiences. Participants were asked about 
the number of days they took off work/normal daily activities; and how many days it took to 
resume eating normally. These were recorded using scores of 0 to 4, assigned respectively to: 
“0 days”, “1-2 days”, “3-5 days”, “6-8 days”, and “still taking time off” or “still not eating 
normally”, respectively. Participants were asked to rate their overall experience: 
“Unacceptable”, “Poor”, “Satisfactory”, “Good”, and “Excellent”. These were scored 0 to 
4 respectively. Participants were also asked if their experience matched their expectations: 
“Not at all”, “Somewhat close”, “Matched exactly” and “Exceeded my expectations”. These 
were scored 0 to 3 respectively.   
 
3.6.3 Oral health impact variables 
The same measure as used in section 3.4.4 was used at follow-up. Changes in scores were 
calculated by subtracting mean OHIP-14 scores at baseline from post-operative scores. A 
positive change indicates a deterioration, and vice versa. The analysis also identified those 
OHIP-14 score changed by at least the minimum important difference (MID) of 4 scale points 
(determined by Locket et al 2004). 
The magnitude of change was calculated by dividing the mean change scores by the standard 
deviation of the score at baseline. This will give us an effect size, 0.2 is considered small, 0.5 
as moderate and 0.8 or above as large.  
 
3.7 Statistical analyses 
The data were analysed using SPSS. Following data cleaning and the computation of 
descriptive statistics, differences in categorical variables were tested for statistical significance 
using chi-square tests, with ANOVA or paired t-tests used for continuous variables. Treatment-





Chapter 4: Results 
 
This chapter will present the data collected in this study and all its analyses. It will be divided 
into 2 main sections, pre-operative data and post-operative data.  
 
4.1 Pre-operative data 
This section will show the data collected at baseline, beginning with the number of 
participants recruited, their anaesthesia preferences and baseline characteristics.  
 
4.1.1 Participation details 
Of the 157 participants recruited, 142 (90.4%) completed the “After surgery questionnaire”. 
Of the remainder, six participants were unable to carry out their surgery during the study period, 
four failed to attend for follow-up, one patient decided to undergo their operation under local 
anaesthesia instead after recruitment, and four patients did not qualify after surgery due to intra-
operative complications (coronectomy and presence of pathology). The low number of 
disqualified participants means that a comparison of their baseline characteristics with those 
who participated would not be informative. All subsequent analyses are restricted to those 142.  
 
4.1.2 Anaesthesia preferences  
Of the 142 participants, 69 (48.6%) chose to have their operation under GA, while 73 (51.4%) 







Table 4.1: Participants’ reasons for anaesthesia method, by group (brackets contain column 
percentages) 
 
In the IV group, “cost and convenience” were listed as biggest reason for this choice; by almost 
a third (30.1%). These reasons were not listed at all by the GA group. While in the GA group, 
almost two-thirds (66.5%) mentioned “nervous”, “needle phobic”, “fear of pain” and “Don’t 
like the procedure” as their reasons for choosing a GA for their operation.  
Appendix G shows participants’ preferences for anaesthesia method before and after their 
consultation.  
Prior to the consultation, 16.2% preferred IV sedation for their operation, and of these, almost 
all (20 out of 23) were happy to proceed without change. Close to half of all the participants 
recruited had a preference for GA, and of these, one in five were happy to change their decision 
to IV sedation. Two out of five participants had no preferences for anaesthesia method, and 




 Group  
 Intravenous sedation General anaesthesia Both Combined 
Nervous & needle phobic   3 (4.1) 25 (36.2) 28 (19.7) 
Fear of Pain   0 (0.0)   5 (7.2)   5 (3.5) 
Friends and family   5 (6.8)   3 (4.3)   8 (5.6) 
Cost & convenience 22 (30.1)   0 (0.0) 22 (7.7) 
Don’t like the procedure   4 (5.4) 16 (23.1) 20 (14.1) 
Preference   7 (9.6)   6 (8.7) 13 (9.2) 
Informed from consultation 18 (24.7) 12 (17.4) 30 (21.1) 
No reason given 14 (19.2)   2 (2.9) 16 (11.3) 
    
Total 73 (100.0) 69 (100.0) 142 (100.0) 
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4.1.3 Participants’ characteristics 
The participants’ demographic characteristics, oral care and smoking habits are presented in 
Table 4.2.  
 
Table 4.2: Socio-demographic, oral self-care and smoking characteristics, by group (brackets 
contain column percentages) 
 Group  
 Intravenous sedation General anaesthesia Both combined 
    
Sex    
Male 29 (39.7) 24 (34.8) 53 (37.3) 
Female 44 (60.3) 45 (65.2) 89 (62.7) 
    
Education level    
Primary/Secondary 19 (26.0) 36 (52.2)a 55 (38.7) 
Tertiary 54 (74.0) 32 (47.8) 86 (61.3) 
    
Community Services 
Card 
   
No 50 (68.5) 43 (62.3) 93 (65.5) 
Yes 23 (31.5) 26 (37.7) 49 (34.5) 
    
Brush twice a day    
No 18 (24.7) 21 (30.4) 39 (27.5) 
Yes 55 (75.3) 48 (69.6)   103 (72.5) 
    
Mouthwash user    
No 44 (60.3) 49 (71.0) 93 (65.5) 
Yes 29 (39.7) 20 (29.0) 49 (34.5) 
    
Current smoker    
No 64 (87.7) 57 (82.6)   121 (85.2) 
Yes   9 (12.3) 12 (17.4)     21 (14.8) 
    
All combined 73 (100.0) 69 (100.0)   142 (100.0) 
    
a P<0.05 
 
Overall, there were slightly more female participants in each group, but this was not statistically 




There were no differences between the groups in oral hygiene habits such as brushing 
frequency and mouthwash usage. Similarly, there was no difference in the number of non-
smokers. 
 
4.1.4 Third molar characteristics 
The number of third molars removed are presented in Table 4.3.  
 
Table 4.3: Number of third molars extracted, by group (brackets contain row percentages 
unless otherwise indicated) 
 Group  
 Intravenous sedation General anaesthesia Both combined a 
    
Number of third molars    
2 17 (85.0)   3 (15.0)b   20 (14.1) 
3 13 (52.0) 12 (48.0)   25 (17.6) 
4 43 (44.3) 54 (55.7)   97 (68.3) 
    
Total 73 (51.4) 69 (48.6) 142 (100.0) 
    
a Column percent 
b P<0.05 
 
The majority of participants in each group, 58.9% and 78.3% respectively, had all four third 
molars removed. However, of the participants who only had both mandibular third molars 









Table 4.4 shows the number of third molars removed by their impaction. 
 
Table 4.4: Number of third molars and surgical characteristics, by group (brackets contain 
column percentages) 
 Group  
 Intravenous sedation General anaesthesia Both combined 
    
Tooth 18    
Simple 33 (66.0) 30 (49.2)a 63 (56.8) 
Surgical 17 (34.0) 31 (50.8) 48 (43.2) 
    
Tooth 28    
Simple 36 (73.5) 29 (49.2)a 65 (60.2) 
Surgical 13 (26.5) 30 (50.8) 43 (39.8) 
    
Tooth 38    
Mesio-angular impaction 25 (34.2) 29 (42.0) 54 (38.0) 
Horizontal impaction 15 (20.5)   9 (13.0) 24 (16.9) 
Vertical impaction 17 (23.3) 16 (23.2) 33 (23.2) 
Disto-angular impaction 16 (21.9) 15 (21.7) 31 (21.8) 
    
Tooth 48    
Mesial impaction 22 (30.1) 24 (34.8) 46 (32.4) 
Horizontal impaction 24 (32.9) 12 (17.4) 36 (25.4) 
Vertical impaction 14 (19.2) 19 (27.5) 33 (23.2) 
Distal impaction 13 (17.8) 14 (20.3) 27 (19.0) 
    
a P<0.05 
 
The type of mandibular impactions in the two groups were evenly distributed, and did not differ 
statistically. However, there were a higher number of maxillary third molars that required 
surgical removal (partially erupted or completely un-erupted teeth requiring the elevation of a 





4.1.5 Dental fear, PANAS scores and OHRQoL  
IDAF-4c scores for dental anxiety were recorded before surgery, and the data are presented by 
group in Table 4.5, along with mean PANAS scores and OHIP-14 summary scores.  
 
Table 4.5: Dental fear, PANAS scores and OHRQoL, at baseline (brackets contain column 
percentages) 
 Group 
 Intravenous sedation General anaesthesia Both combined 
    
Mean IDAF-4C (SD) 14.4 (6.5) 19.0 (9.7)a 16.7 (8.5) 
    
Dentally fearful      9 (12.3)    23 (33.3)a    32 (22.5) 
    
PANAS scale score    
Positive Affect 34.0 (6.0) 34.3 (7.5) 34.1 (6.7) 
Negative Affect 19.8 (5.3) 23.0 (7.1)a 21.4 (6.4) 
    
Mean OHIP-14 score 13.0 (7.9) 13.5 (11.6) 13.2 (9.8) 
    
a P<0.05 
 
Those who opted for treatment under GA scored higher (on average) on the IDAF-4AC anxiety 
scale and the PANAS negative affect scale. There was no difference in the PA scores between 
the groups, but there was a statistically higher NA score in the GA group. There was also no 






Data on the occurrence of pain at baseline are presented in Table 4.6.  
 
Table 4.6: Pre-operative pain history, by group (brackets contain column percentages) 
 Group  
 Intravenous sedation General anaesthesia Both combined 
    
Pre-operative pain    
No   6 (8.2)   5 (7.2)a   11 (7.7) 
Yes 67 (91.8) 64 (92.8) 131 (92.3) 
    
Intensity of pain    
Mild 18 (24.7) 14 (20.3) 32 (24.4) 
Moderate 36 (49.3) 29 (42.0) 65 (49.6) 
Severe 13 (17.8) 21 (30.4) 34 (26.0) 
    
Frequency of Pain     
Occasionally 19 (26.0) 27 (39.1) 46 (35.1) 
Sometimes 21 (27.4) 19 (27.5) 40 (30.5) 
Often 25 (34.2) 13 (18.8) 38 (29.0) 
Always   2 (2.7)   5 (7.2)   7 (5.3) 
    
a P<0.05 
Overall, over 90% of both groups had a history of third molar pain at some point in the four 




Mean PANAS scores are presented by pre-operative pain occurrence in Table 4.7.  
 
Table 4.7: Pre-operative PANAS score, by pain history (brackets contain standard deviation) 
  Mean PANAS scores 
 Positive Affect Negative Affect 
   
Pre-operative pain   
No 31.6 (7.8) 19.2 (4.1) 
Yes 34.3 (6.6) 21.6 (6.5) 
   
Intensity of pain   
Mild 34.9 (4.9) 19.8 (4.0)a 
Moderate 33.8 (6.9) 20.4 (6.3) 
Severe 34.9 (7.5) 25.5 (7.4) 
   
Frequency of Pain    
Occasionally 34.6 (6.2) 20.2 (4.8) 
Sometimes 33.8 (6.8) 21.7 (6.8) 
Often 34.9 (6.8) 22.5 (7.1) 
Always 31.0 (7.3) 25.1 (10.9) 
   
a P<0.05 
 
Those who reported severe pain at baseline had higher negative affect scores (on average) than 
those who did not. There was also a gradient in negative affect scores by pain frequency, but 





4.2 Post-operative data 
The next section in this chapter will show the data collected at the participants’ surgical review 
appointment, 10-14 days after their procedure. This chapter will finish with analyses on the 
change in OHRQoL using the OHIP-14 data.  
 
4.2.1 Surgical outcomes 
Table 4.8 shows the data collected from participants in the post-operative period in terms of 
























Table 4.8: Post-operative recovery, by group (brackets contain column percentages) 
 
 Group  
 Intravenous sedation General anaesthesia Both combined 
    
Taking prescribed 
medication 
   
No   1 (1.4)   0 (0.0)     1 (0.7) 
Yes 72 (98.6) 69 (100.0) 141 (99.3) 
    
Medication working    
No   8 (11.0)   6 (8.7)   14 (9.9) 
Yes 65 (89.0) 63 (91.3) 128 (90.1) 
    
Took more medication    
No 67 (91.8) 59 (85.5) 126 (88.7) 
Yes   6 (8.2) 10 (14.5)   16 (11.3) 
    
Saw a medical doctor    
No 72 (98.6) 65 (94.2) 137 (96.5) 
Yes   1 (1.4)   4 (5.8)     5 (3.5) 
    
Pain following surgery    
No pain/Mild pain 15 (20.5) 21 (30.4)a   36 (25.4) 
Moderate Pain 36 (49.3) 37 (53.6)   73 (51.4) 
Severe/Excruciating pain 
& agony 
22 (30.1) 11 (15.9)   33 (23.2) 
    
Nausea    
No 65 (89.0) 35 (50.7)a 100 (70.4) 
Yes   8 (11.0) 34 (49.3)   42 (29.6) 
    
Sore Throat    
No 63 (86.3) 27 (39.1)a   90 (63.4) 
Yes 10 (13.7) 42 (60.9)   52 (36.6) 
    
Dry Socket    
No 67 (91.8) 63 (91.3) 130 (91.5) 
Yes   6 (8.2)   6 (8.7)   12 (9.5) 
    
All combined 73 (100.0) 69 (100.0) 142 (100.0) 
    
a P<0.05 
 
All but one participant in the entire sample took the prescribed medication, with nearly 10% of 
participants commenting it was not effective enough. One in nine patients resorted to rescue 
medication of their own choice. Of those, four took Tramadol, four took different non-steroidal 
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anti-inflammatory drugs (NSAIDs) such as celecoxib and diclofenac, three preferred a 
combination medication such as Panadeine© and Maxigesic©, one took antibiotics 
(Augmentin), two participants took herbal supplements, one took more codeine, and one 
participant did not explain. There were no apparent differences between the groups.  
There was a significant difference between IV and GA groups with the incidence of sore throats 
and nausea with well over half of the participants in the GA group experiencing a sore throat, 
while only one in seven of the IV group reporting it. One in nine participants in the IV group 
had nausea, but almost half (49.3%) of those in the GA group had it.  
The pain reported after surgery also differed between the groups, with three in ten participants 
in the IV group reported pain after surgery to be “Severe” and “Excruciating pain & agony”. 
This experience was more favourable in the GA group, with only 11 participants reaching this 
level of discomfort. 
 
4.2.2 Self-reported outcomes 
In this section, patient self-reported data (such as the number of days off work, number of days 













Table 4.9: Recovery after surgery, by group (brackets contain column percentages) 
 
 Group  
 Intravenous sedation General anaesthesia Both combined 
    
Days taken off    
0    5 (6.8)   2 (2.9)a   7 (4.9) 
1-2  26 (35.6) 10 (14.5) 36 (25.4) 
3-5  32 (43.8) 34 (49.3) 66 (46.5) 
6 or more 10 (13.7) 23 (33.3) 33 (23.3) 
    
Days eating affected    
0    3 (4.1)   0 (0.0)   3 (2.1) 
1-2    7 (9.6)   6 (8.7) 13 (9.2) 
3-5  16 (21.9) 21 (30.4) 37 (26.1) 
6 or more 47 (64.4) 42 (60.9) 89 (62.7) 
    
Overall satisfaction   
Poor    0 (0.0)   1 (1.4)   1 (0.7) 
Satisfactory    6 (8.2)   3 (4.3)   9 (6.3) 
Good 28 (38.4) 33 (47.8) 61 (43.0) 
Excellent 39 (53.4) 32 (46.4) 71 (50.0) 
    
    
Expectation    
Not at all   4 (5.5)   3 (4.3)   7 (4.9) 
Somewhat close 16 (21.9) 20 (29.0) 36 (25.4) 
Matched  32 (43.8) 31 (44.9) 63 (44.4) 
Exceeded  21 (28.8) 15 (21.7) 36 (25.4) 
    
a P<0.05 
 
In both groups, almost half—43.8% and 49.3% respectively—took 3-5 days off work and/or 
normal duties after surgery. Only one in eight participants in the IV group took longer than six 
days off, while a third in the GA group took a similar time.  
A large proportion of participants found their eating pattern to be affected for more than six 
days while only three participants—all from the IV group—resumed normal eating pattern 
immediately after surgery. This difference did not reach statistical significance (P=0.37). 
Overall satisfaction between the two groups were comparable with just over half of the IV 
participants reporting “Excellent” and 72.6% commenting that it either “Matched” or 
“Exceeded” their expectations. Conversely, the GA participants had similar outcomes with just 
under half reporting “Excellent” for satisfaction and a third had their expectations “Matched” 
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or “Exceeded”. Only one participant was dissatisfied, reporting “Poor” satisfaction.  These 
differences between the groups also failed to reach statistical significance (P=0.39).  
 
Mean PANAS scores are presented by categories of recovery in Table 4.10.  
 
Table 4.10: Mean PANAS scores, by categories of recovery days affected, overall satisfaction 
and participants expectations (brackets contain standard deviation) 
 
 Mean PANAS scores 
 Positive affect Negative affect 
   
Days taken off   
0  27.7 (9.3) 18.7 (4.8)a 
1-2  33.5 (6.8) 21.6 (6.7) 
3-5  34.9 (6.0) 20.8 (5.5) 
6-8  34.9 (6.7) 22.1 (7.2) 
8 or more 32.4 (9.2) 27.8 (10.1) 
   
Days eating affected   
0  39.0 (5.6) 19.0 (5.6) 
1-2  34.6 (6.3) 21.2 (7.1) 
3-5 34.6 (7.3) 21.5 (6.3) 
6-8  33.1 (6.9) 21.0 (5.8) 
8 or more 35.0 (6.0) 22.4 (7.8) 
   
Overall Satisfaction    
Poor 34.0 (0.0) 33.0 (0.0) 
Satisfactory 34.3 (7.4) 20.3 (5.0) 
Good 32.8 (7.1) 21.4 (6.2) 
Excellent 35.2 (6.7) 21.3 (6.7) 
   
Expectation   
Not at all 36.4 (4.0) 22.0 (7.0) 
Somewhat close 32.5 (6.9) 22.9 (5.7) 
Matched  34.6 (6.8) 21.3 (7.2) 
Exceeded  34.4 (6.9) 19.9 (5.3) 




There was no statistical significance across eating pattern, satisfaction and expectations, 
however, the category worthy of note was in “Days taken off”. In this category, there was a 
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gradual ascending gradient of negative affect (NA) scores, from “0 days taken off” to “8 or 
more days taken off”. This gradient was not evident with the positive affect (PA).  
 
4.2.3 Oral health-related quality-of-life 
OHIP-14 data were collected again at surgical review, and the differences are shown in Table 
4.11.  
 
Table 4.11: Oral Health Impact Profile (OHIP) scores before and after surgery, by group 
(brackets contain standard deviation) 
 Group  
 Intravenous sedation General anaesthesia Both Combined 
    
Mean OHIP-14 Before surgery  13.0 (7.9) 13.5 (11.6) 13.2 (9.8) 
Mean OHIP-14 After surgery 19.3 (7.4) 20.3 (9.4)a 19.8 (8.4)a 
Mean change in score   6.3 (8.7)   6.8 (13.0)   6.6 (11.0)a 
Effect Size   0.8 (large)   0.6 (moderate)   0.6 (moderate) 
    
Number who worsenedb    39 (53.4)    40 (58.0)    79 (55.6) 
Number who did not change    27 (37.0)    20 (29.0)    47 (33.1) 
Number who improved      7 (9.6)      9 (13.0)    16 (11.3) 
    
a P<0.05 
b By the minimally important difference of 4 scale points, after Locker et al., 2004 
 
 
Irrespective of anaesthesia method, OHIP-14 scores worsened post-operatively, being 19.3 (sd, 
7.4) and 20.3 (9.4) in the IV and GA groups respectively. The effect sizes were moderate to 
large. When the participants were organised by minimum important difference (MID), it 
showed that both groups had similar recovery experiences.  
Further analyses with MID was made and grouped with mean PANAS scores. The results are 





Table 4.12: Mean PANAS scores, by categorised change in OHIP-14 score (brackets contain 
standard deviation) 
  Mean PANAS scores 
 Positive Affect Negative Affect 
   
Number who worsenedb 35.3 (6.1) 20.2 (4.6)a 
Number who did not change 32.1 (7.2) 21.0 (6.9) 
Number who improved 34.3 (7.7) 28.2 (8.5) 
   
a P<0.05 
b By the minimally important difference of 4 scale points, after Locker et al., 2004 
 
 
When mean PANAS scores were categorised by MID, an ascending gradient in NA was 




4.2.4 Multivariate logistic regression analysis 
Table 4.13 shows a logistic regression model carried out for participants taking longer than 3 
days off work after the operation, controlling for relevant baseline characteristics.  
 
Table 4.13: Logistic regression model for 3 or more days off post-surgery 
 
 Odds ratio (95% CI)a P value 
   
Opted for GA 3.80 (1.66, 8.70) 0.002 
Female 1.31 (0.60, 2.86) 0.498 
PANAS NA score 0.99 (0.92, 1.06) 0.711 
Baseline IDAF-4C score 0.93 (0.60, 1.44) 0.744 
   
a Hosmer and Lemeshow test: P=0.989 
 
This multivariate analysis shows that patients who opted for GA—once controlling for gender, 
NA scores and baseline dental fear—had an almost 4 times greater chance of taking 3 or more 





Chapter 5: Discussion 
 
5.1 Overview 
The primary objective of this study was to compare the surgical outcomes of intravenous 
sedation and general anaesthesia after third molar surgery. In addition, I evaluated the influence 
of factors such as personality on patients’ choice of anaesthesia and whether this had any 
influence on surgical outcomes.  
This is one of the few studies to have compared IV sedation and GA with respect to post-
operative recovery after third molar surgery. Chye and co-workers compared these two 
anaesthesia methods and reported a lower incidence of post-operative nausea and vomiting 
(PONV) in the IV group and a quicker time to discharge (Chye et al., 1993).  However, the 
patients in this study were not given a free choice, and the decision was made by the surgeon 
after review of the individual cases. There is evidence that patients who are able to choose their 
anaesthesia method are more accepting of their procedure than those who are randomly 
allocated (Bain et al., 2001).  
Other studies to have compared IV sedation and GA have generally concluded that sedation 
can be carried out instead of a GA, and—at times—provide a quicker and less complicated 
recovery (Van Sickels and Tiner, 1992; Rastogi et al., 2014; Mehra and Arya, 2015). The 
procedures carried out in those studies were more invasive that third molar surgery, and so a 
deeper sedation technique was utilised. Even so, their findings also confirm that IV sedation 
can provide a quicker recovery from the operation. 
In the discussion that follows, methodological issues will be considered first. Following that, 
this chapter will be structured according to the research questions. They were: (i) is there a 
difference in surgical outcomes in third molar surgery between IV sedation and GA; (ii) what 
is the impact of psychosocial characteristics on anaesthesia choice and surgical outcomes; and 
(iii) what are the factors that influence the choice of anaesthesia method in third molar surgery? 
The chapter will conclude with the implications of the study findings, along with future 




5.2 Methodological issues 
Before discussing the findings of this study, it is appropriate to scrutinise the methods used. 
The study design, sample size, statistical power, and questionnaire design will also be 
considered.  
 
5.2.1 Study design 
This study was a prospective, quasi-experimental study. A quasi-experiment is a situation in 
which the researcher does not have full control over the allocation of the intervention—in this 
case, the allocation of IV sedation or GA. Due to this study design, there was an element of 
bias in this methodology. Patients were able to have a free choice as to which method they will 
have for the operation, ultimately resulting in more NA and dentally fearful patients in the GA 
group. In an ideal world, this study would be a RCT, where participants were randomly 
allocated to either IV sedation or GA for their operation—thus eliminating the source of bias—
but ethical constraints meant that I would have been unable to "coerce" certain patients to have 
their operation under IV sedation when they wanted a GA or vice versa. Costs are higher for a 
GA, and some patients chose IV sedation because their operation would be cheaper and could 
be scheduled earlier. The nature of the influences on patients’ choice of anaesthesia method 
was a key research question in this study. Why do certain patients choose a GA rather than IV 
sedation?  
 
5.2.2 Study sample 
A clinical convenience sample was utilised for this study, and participants were recruited from 
patients who presented to the Faculty of Dentistry, University of Otago. Participants had to fit 
between the ages of 16 and 35 years of age and into the inclusion criteria, as outlined in section 
3.3.2. Unsurprisingly, the sample comprised of mainly young, healthy adults, and so it is not a 
representation of the general population.  
However, the routine removal of third molar surgery is usually carried out in this age group, 
since this is the developmental epoch when initial discomfort develops, prompting a visit to 
their dentist. It could be said that this sample is a fitting representation, since this age group is 
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more likely to have third molar surgery and more likely to be more forthcoming about their 
pain experiences, arguably. 
 
5.2.3 Statistical power 
This study had a minimum requirement of 73 participants in each group, assuming an α value 
of 0.05 and a power of 0.8 to detect a difference. This is on the basis that 60% of those in the 
GA group and 80% in the IV group will report “good” or “excellent” in their experience. The 
recruitment process was better than the minimum required (157); however, a small attrition 
rate meant a slightly smaller GA group (69). This reduction in number was minimal. The 
findings showed that the sample size was adequate, and the attrition rate was unlikely to 
influence the data or results. That is, there was adequate statistical power and the loss of some 
patients was unlikely to have affected the findings.  
 
5.2.4 Pain 
This study did not utilise a VAS scale for patient self-reported pain experience. Instead, an 
ordinal scale (VRS) consisting of 5 levels of pain ranging from “no pain” to “excruciating 
pain & agony” was used. The VAS scale is a standard that is frequently used to evaluate pain 
after surgery. However, it was the hope of the author that by using more appropriate descriptors 
of pain, patients could use this simpler method to report their pain more accurately. 
 
5.3 Research Questions 
5.3.1 Is there a difference in surgical outcomes in third molar surgery between IV 
sedation and GA? 
When comparing participant recovery, outcome measures were assessed objectively through 
OHIP-14 scores and self-reported outcomes (such as days off work). The OHIP-14 data suggest 
that there will be a worsening in patients’ OHRQoL following third molar surgery, irrespective 
of the anaesthesia method used. The effect sizes for these changes were moderate to large. This 
is consistent with the existing literature, where a definite deterioration in patients’ OHRQoL in 
the first week is usually observed (Chapter 1.2.3.2). Interestingly, when participants were asked 
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to comment on the number of days taken for recovery, the majority of participants in the IV 
group took less than 6 days off, while GA participants took more days off significantly. Even 
though OHRQoL had worsened equally for both groups, the IV participants recovered more 
quickly. Perhaps this can be attributed to the more involved process of having a GA, given that 
they are seen and treated in a hospital setting, with the addition of all the medications required 
to induce GA. A higher incidence of PONV and a sore throat in this group might also be a 
contributory factor. The incidence of these complications was much greater in the GA group, 
but this was to be expected, because PONV is a well-known complication of a GA, with the 
intubation process and the use of a throat pack being the main reason for a sore throat.  
In terms of the deterioration of patients’ eating pattern in the recovery phase, there were no 
differences between the two groups. The even distribution of mandibular third molar 
impactions across the two groups suggests that recovery would be similar from a surgical 
standpoint. The greater number of upper third molars requiring surgical removal in the GA 
group did not seem to have an impact on patients’ eating pattern post-operatively. This suggests 
that the recovery from surgery was not heavily influenced by the operation per se, but instead 
from the GA itself. 
Interestingly, the IV group reported more pain following surgery. Almost one-third of that 
group reported “Severe” and “Excruciating pain & agony” while it was one in ten in the GA 
group. With such a difference in pain experience, it might be expected that this would impact 
socially and functionally, and be reflected in the overall OHRQoL score; but this was not 
evident in the findings. In fact, GA participants reported a longer recovery period, albeit 
reporting lower pain. A possible explanation for this difference could be the significantly 
higher number of tertiary-educated patients in the IV group. Perhaps this higher overall level 
of education had an influence on their ability to cope; or perhaps patients’ level of education 
influenced their ability to report pain, whether more accurately or at a heightened level. This 
raises the question, “does patients’ level of education influence their ability to cope after 
surgery?”.  
Both groups reported the same level of satisfaction from surgery. Even though with the 
different outcomes in days off and pain as mentioned above, participants mentioned that their 
surgery met their expectations and were satisfied with the outcome. Perhaps this was not due 
to the pain and discomfort from surgery, but rather from the amnesic qualities of both IV 
sedation and GA.  
57 
 
Critically, the issue of bias in this study must be addressed. As mentioned in section 5.2.1, this 
was carried out as a quasi-experimental design, where patients can freely choose their method 
of surgery. This will inherently introduce a level of bias in this study because participants that 
are dentally fearful—and in this study higher NA scores—will more likely opt for a GA, thus 
affecting the result. To control for these confounding factors, multivariate logistic regression 
analysis (Section 4.2.4) was used and showed that patients who had their operation under GA—
once controlling for gender, NA scores and dental fear—had an almost four times greater risk 
to take more than 3 days off after surgery.  
All things being equal, the findings suggest that the benefits of IV sedation outweigh those of 
a GA. The surgical outcomes might be similar in terms of deterioration of OHRQoL, eating 
pattern, and satisfaction, but patient self-reported outcomes are more positive with IV sedation, 
notwithstanding the greater post-operative pain.  
 
5.3.2 What is the impact of psychosocial characteristics on anaesthesia choice and surgical 
outcomes? 
The investigation into patient’s psychosocial characteristics in dentistry—such as dental fear 
and anxiety—is nothing new. However, little has been done in terms of evaluating its impact 
on treatment outcomes and satisfaction.  
As reported previously, personality not only impacts on self-reported oral health, but also 
influences clinical conditions such as dental caries (Thomson et al., 2011). It is logical to 
conclude that psychosocial characteristics may impact on surgical outcomes, in the current 
case, the surgical removal of third molar teeth. The Negative Emotionality domain comprises 
the three sub-categories of aggression, alienation and stress reaction. These indicate a degree 
of intimidation, victimisation/mistreatment, and nervousness/catastrophising, respectively. 
The PANAS NA scale does not permit investigation of these because of its relative brevity, 
and so these aspects were unable to be explored in this study. However, it is logical to assume 
that those scoring higher on NA in the current study would have scored higher on all three of 
those.  
There was a definite pattern with the patients scoring higher on NA in the PANAS scale in the 
current study. The findings suggest that patients scoring high on negative emotionality will 
take more time off after surgery. They also tend to report a greater severity and frequency of 
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pain pre-operatively and are more likely to choose a GA for their operation. What could be the 
reason for this? Could it be that patients with a greater degree of psychosocial traits such as 
mistreatment and catastrophising influenced their recovery? Do these negative traits introduce 
a degree of acopia (that is, being unable to cope as well) in patients? Or was the longer recovery 
attributed to associated complications such as a sore throat and PONV? Complications from 
the GA itself can indeed worsened post-operative recovery, but when the mean PANAS scores 
were examined by recovery group, it showed that, irrespective of anaesthesia method, 
participants scoring higher on negative emotionality took significantly more time off daily 
activities. This suggests that the technical and clinical complications of a GA had little 
influence on patient recovery.  
The current study also found participants scoring higher on NA showed the greatest 
improvement in their OHIP-14 scores. This was a surprising finding, especially when these 
were the individuals that took more days off.  
This study was not able to determine whether it was the GA that caused the longer recovery, 
or whether it was patients’ pre-existing personality traits that influence their surgical outcomes. 
Further research is warranted in this area; as the study findings suggest that no single outcome 
measure can be used to evaluate patient recovery. 
 
5.3.3 What are the factors that influence the choice of anaesthesia method in third molar 
surgery?  
In the current literature, the choice of anaesthesia is predominantly decided by the treating 
clinician, their evaluation of the patient’s medical status, the difficulty of the surgery, and the 
available facilities. There are no studies to date investigating patient-related choice and their 
outcomes.  
The current study gave participants a free choice between (a) LA with IV sedation and (b) GA 
for their operation. By doing so, it was the aim to determine the reasons for their choice and 
whether the consultation process had an influence.  
The choices that participants made can be seen in Appendix G. There was a considerable low 
proportion of participants requesting IV sedation, while almost half requested a GA. This 
finding may be attributed to two possibilities; was it: (1) the perception that third molar surgery 
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is (or should be) carried out under a GA; or (2) were patients unaware of the available option 
of IV sedation? The second biggest reason for GA was their perceived knowledge of the 
procedure. Whether this was influenced by friends and family or from the internet and social 
media was not investigated. Only one-fifth of GA-preferring participants were willing to 
change to IV sedation after their surgical consultation. It is evident from the findings that, even 
after the consultation, patients’ underlying fears and anxiety prove a difficult hurdle for change.  
The findings from this study suggest two potential clinical reasons for their choice of 
anaesthesia method. The first consideration was the number of third molars removed per 
patient. There was a significant difference in choice when only the two mandibular third molars 
needed to be removed. Of those cases, almost nine out of 10 chose to have IV sedation. There 
was no difference in choice when three or all four third molars were indicated for extraction. It 
is logical to attribute this to participants’ anticipant of greater pain and discomfort when all 
third molars were to be removed, rather than two. Even though the removal of maxillary third 
molars may result in fewer complications and less discomfort than for their mandibular 
counterparts, psychologically, patients may still find it difficult to understand.  
The second clinical reason for choice was the surgical difficulty of the upper third molars. 
Participants choosing IV sedation had significantly fewer upper third molars (30 out of 69 
maxillary third molars) requiring surgical removal (requiring elevation of a mucoperiosteal flap 
and bone removal). In the GA group, there was an even distribution, (almost 50/50) in 
maxillary third molars requiring surgical removal. This finding suggests that the surgical 
difficulty of the maxillary teeth had a greater influence on patient choice. However, was this 
choice influenced by the clinician? An impacted 18 or 28 is often more difficult to access, and 
the associated surgical discomfort to the patient can be greater than for an impacted mandibular 
third molar. It can also be argued that unerupted upper third molars are rarely symptomatic, 
and their removal is usually prophylactic, and hence, a patient’s choice. Perhaps qualitative 
research might provide better explanation of this. 
A noteworthy finding on choice was the higher number of tertiary educated participants in the 
IV group, as mentioned in section 5.3.1. This was not seen with CSC status, so I am not able 
to conclude that social status was a factor, as Sammut et al did in their study (Sammut et al., 
2013). However, it certainly begs the question of whether the education level of the patients 
had an influence on their choice. Is it because they were better educated and, hence, better able 
to understand the process of the operation and make a better clinical choice? Or did personality 
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traits once again influence this choice, since there was a significant difference in NA scores 
between the groups (Table 4.5)? Or was higher level of education related to lower scores in 
NA and vice versa? Or could the deciding factor be anxiety and dental fear? Almost two-thirds 
of the participants in the GA group mentioned nervousness, fear, and the thought of the 
procedure itself as their reason for choosing a GA. Even though a GA costs more, has a longer 
waiting period and has more unwanted complications, their psychosocial traits, and perhaps 
their level of education might be the deciding factor.  
The question of choice remains difficult to answer. Educational, clinical and psychological 
factors play a synergistic role in patients’ decisions. It is not possible to determine—from the 
findings of this study—that only one factor influences their choice. The evidence presented 
here suggests that patients’ psychological and personality characteristics do indeed influence 
that choice, with NA scores being higher (on average) among those opting for treatment under 
GA, and this has a knock-on effect on surgical outcomes. However, further research is needed 
to validate and confirm this finding. 
 
5.4 Implications of the study findings 
What are the practical clinical implications of this study? Regardless of surgical difficulty, a 
patient’s recovery is unpredictable. Clinical measures—such as surgical methods and 
medication regimen—have been studied extensively. Most studies have concluded that one 
approach is not superior to the other in relation to patient recovery. Should clinicians include a 
measure of negative emotionality during their initial consultation and evaluation for surgery? 
Practically, it may not be feasible for every patient to complete a PANAS questionnaire, 
because clinicians are unlikely to have the skills to correctly interpret the resultant data. 
However, dental practitioners should appreciate that their patients differ in their psychological 
characteristics and that these can influence both their choices and their recovery path. 
Accordingly, through rapport and relationship building, management of our patients will go 
beyond what we can measure clinically and physically see.  
What can other possible application be derived from this study? As noted in Thomson's study, 
personality has been shown to be dynamic throughout our lifetime, with the ability to change 
through experience and lifestyle (Thomson et al., 2011). In addition, the use of a brief cognitive 
intervention has been used successfully to change patients’ perceptions and negative attitudes 
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in medical treatment (Gulliksson et al., 2011). Thus, it is not unreasonable to suggest that the 
use of brief cognitive therapy in dentistry could be a valid method to aid in providing optimum 
dental care. Perhaps more in-depth study and the better understanding of psychosocial factors 
and perceptions—using mixed qualitative and quantitative methods—may be warranted. This 
may result in the development of patient-specific consultation and custom tailored post-
operative instructions to certain "patient types". 
The majority of third molar removal can be carried out simply under LA, with or without 
sedation in the dental setting. However, there are specific situations where a GA in a hospital 
environment is recommended. Dental fear remains a large problem in the general population 
and, in this study, these patients tended to choose a GA for their operation. This ultimately has 
a flow-on effect on costs, hospital waiting lists and surgical outcomes. The management of 
dental fear remains one of the challenges of dentistry and thus, further development into patient 
management and sedation techniques could relieve pressure from waiting lists, especially in 
the public sector.  
This study also confirms the safety (and acceptance by patients) of the use of single agent 
midazolam alone for the surgical removal of third molar teeth, without the need for stronger 
medications such as propofol, remifentanil and/or fentanyl. When titrated to effect, this is a 
relatively safe technique for conscious sedation and it allows this type of surgery to be provided 
easily in the dental setting, without the need and cost of a hospital environment, and with 
acceptable shorter post-operative recovery times. 
 
5.5 Future directions 
Multiple factors can influence the recovery of a patient after undergoing surgical removal of 
third molar teeth. In fact, the outcome of any treatment can be unpredictable. The evaluation 
of patient recovery from objective clinical measures—while useful—may not be as relevant to 
patients. The study into psychosocial characteristics is in its infancy in dentistry, and further 
research is required in this area to better provide for our patients. 
Negative emotionality has a clear impact on our patients’ own perception of oral health, the 
choices they make, and on their surgical outcome. The influence it has on choice is evident in 
this study, but it is neither practical nor ethical for patients to complete a PANAS questionnaire 
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prior to consultation. However, it is possible to develop specific questions for new patient 
registration forms to collect the necessary information; or an alternative (and subtler) approach 
could be the development of questioning strategies during the consultation process. Clinicians 
may then be able to utilise this information to better apprise patients of the likely outcomes and 
set expectations more accurately.  
The study and use of psychological traits—as mentioned previously—is a new concept in 
dentistry. The current literature has shown that it has a large role in dentistry, and its influence 
in patient care is worth noting. However, at the time of writing, there is no allowance made for 
this area in the undergraduate dental curriculum at the University of Otago. Future 
considerations might be the inclusion of psychosocial characteristics and aspects of psychology 
into the education of future dental graduates.  
Public awareness of dentistry is an area that requires improvement, not just for third molar 
surgery. This study showed that the perception of this type of surgery is poor and patients’ 
preconceived knowledge and fears play a large part in their decision making. Future efforts can 
be made to raise public awareness of the true nature of treatment. This is no doubt a 





Chapter 6: Conclusion 
 
This study aimed to compare the two anaesthesia methods of LA with IV sedation and GA. 
Participants that had a tertiary education tended to choose IV sedation for their operation, while 
dentally fearful patients and patients higher in negative emotionality were more likely to choose 
a GA for their third molar operation. GA patients also reported taking more days off in their 
recovery, as well as reporting a higher incidence of a sore throat and nausea post-operatively.  
Individuals of higher negative emotionality—regardless of anaesthesia method—also took 
more days off normal daily activities.  
The findings suggest that patients’ psychological and personality characteristics do indeed 
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Appendix G: Participants anaesthesia preferences, before and after 
consultation 
 
 
 
